Literature DB >> 29490181

Antibody-Mediated Encephalitis.

Josep Dalmau1, Francesc Graus1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29490181     DOI： 10.1056/NEJMra1708712

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  211 in total

1.  Epidemiology of paraneoplastic neurological syndromes: a population-based study.

Authors:  Alberto Vogrig; Gian Luigi Gigli; Samantha Segatti; Elisa Corazza; Alessandro Marini; Andrea Bernardini; Francesca Valent; Martina Fabris; Francesco Curcio; Francesco Brigo; Donatella Iacono; Paolo Passadore; Michele Rana; Jérôme Honnorat; Mariarosaria Valente
Journal:  J Neurol       Date:  2019-09-24       Impact factor: 4.849

2.  Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.

Authors:  Yan Zhang; Gang Liu; Mengdi Jiang; Weibi Chen; Yanbo He; Yingying Su
Journal:  Neurocrit Care       Date:  2018-10       Impact factor: 3.210

3.  Th17 lymphocytes drive vascular and neuronal deficits in a mouse model of postinfectious autoimmune encephalitis.

Authors:  Maryann P Platt; Kevin A Bolding; Charlotte R Wayne; Sarah Chaudhry; Tyler Cutforth; Kevin M Franks; Dritan Agalliu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-11       Impact factor: 11.205

4.  Sleep disturbances are common in patients with autoimmune encephalitis.

Authors:  Margaret S Blattner; Gabriela S de Bruin; Robert C Bucelli; Gregory S Day
Journal:  J Neurol       Date:  2019-02-11       Impact factor: 4.849

Review 5.  Diagnosing autoimmune limbic encephalitis.

Authors:  Adrian Budhram; Andrew Leung; Michael W Nicolle; Jorge G Burneo
Journal:  CMAJ       Date:  2019-05-13       Impact factor: 8.262

6.  Psychosis of dual origin in HIV infection: Viral escape syndrome and autoimmune encephalitis.

Authors:  David Anguizola-Tamayo; Jone Bocos-Portillo; Lara Pardina-Vilella; Aida Rodriguez-Sainz; Iñigo Vicente-Olabarria; Eduardo Martínez; Marian Gomez-Beldarrain; Juan Carlos Garcia-Monco
Journal:  Neurol Clin Pract       Date:  2019-04

Review 7.  Anti-NMDA receptor encephalitis: a review of mechanistic studies.

Authors:  Yue-Qiao Huang; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2021-02-15

Review 8.  Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer.

Authors:  Iosune Baraibar; Ignacio Melero; Mariano Ponz-Sarvise; Eduardo Castanon
Journal:  Drug Saf       Date:  2019-02       Impact factor: 5.606

9.  Clinical and pathogenic significance of IgG, IgA, and IgM antibodies against the NMDA receptor.

Authors:  Makoto Hara; Eugenia Martinez-Hernandez; Helena Ariño; Thais Armangué; Marianna Spatola; Mar Petit-Pedrol; Albert Saiz; Myrna R Rosenfeld; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2018-03-16       Impact factor: 9.910

10.  Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABAA receptor encephalitis.

Authors:  Simone M Brändle; Manuela Cerina; Susanne Weber; Kathrin Held; Amélie F Menke; Carmen Alcalá; David Gebert; Alexander M Herrmann; Hannah Pellkofer; Lisa Ann Gerdes; Stefan Bittner; Frank Leypoldt; Bianca Teegen; Lars Komorowski; Tania Kümpfel; Reinhard Hohlfeld; Sven G Meuth; Bonaventura Casanova; Nico Melzer; Eduardo Beltrán; Klaus Dornmair
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.